He is Medical Director for the Aging Brain and Memory Clinic, an investigator with the Cognitive Clinical Trials Group, Program Director of the South Western Ontario Regional Geriatric Program.
His research interests include predictors of conversion from mild cognitive impairment (MCI) to Alzheimer Disease (AD), including sensitive Neuroimaging techniques, and randomized controlled trials of new treatments for MCI and AD. He is President of the Consortium for Canadian Centres for Clinical Cognitive Research (C5R).
Consortium for Canadian Centres for Clinical Cognitive Research (C5R)
Canadian Consortium on Neurodegeneration on Aging (CCNA)